lintuzumab-acy225
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for lintuzumab-acy225, covering 2023-08-04 to 2023-08-04. Get the full timeline:
Most recent: Clinical Trial Update: Venetoclax and Lintuzumab-Ac225 in AML Patients [Phase 1, Phase 2]